|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2006-9-12
|
|
pubmed:abstractText |
There are virtually no controlled data suggesting that concomitant psychotropic medications (CPMs) improve outcome in schizophrenia after the acute phase. Despite that, polypharmacy (with all of its disadvantages) is far more common than monotherapy. To our knowledge, there have been no published reports of prospective systematic investigations of the efficacy of unrestricted CPM use in nonacute schizophrenia.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0160-6689
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
67
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1261-5
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16965205-Adolescent,
pubmed-meshheading:16965205-Adult,
pubmed-meshheading:16965205-Anticonvulsants,
pubmed-meshheading:16965205-Antidepressive Agents,
pubmed-meshheading:16965205-Antipsychotic Agents,
pubmed-meshheading:16965205-Chronic Disease,
pubmed-meshheading:16965205-Dose-Response Relationship, Drug,
pubmed-meshheading:16965205-Drug Administration Schedule,
pubmed-meshheading:16965205-Drug Therapy, Combination,
pubmed-meshheading:16965205-Female,
pubmed-meshheading:16965205-Humans,
pubmed-meshheading:16965205-Longitudinal Studies,
pubmed-meshheading:16965205-Male,
pubmed-meshheading:16965205-Middle Aged,
pubmed-meshheading:16965205-Polypharmacy,
pubmed-meshheading:16965205-Prospective Studies,
pubmed-meshheading:16965205-Psychiatric Status Rating Scales,
pubmed-meshheading:16965205-Psychotropic Drugs,
pubmed-meshheading:16965205-Schizophrenia,
pubmed-meshheading:16965205-Schizophrenic Psychology,
pubmed-meshheading:16965205-Treatment Outcome
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Concomitant medications may not improve outcome of antipsychotic monotherapy for stabilized patients with nonacute schizophrenia.
|
|
pubmed:affiliation |
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA 94305, USA. iraglick@stanford.edu
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial
|
